SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Business Responsibility and Sustainability Reporting (BRSR)
BRSR attached31-07-2023
Sun Pharma, Alembic recall drugs in US market
According to the USFDA, the companies are recalling products due to manufacturing issues.30-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Notice of 31st Annual General Meeting of the Company.29-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - 31St Annual General Meeting To Be Held On Monday, August 28, 2023
The 31st AGM of the members of Sun Pharmaceutical Industries Limited will be held on Monday, August 28, 2023 at 3:00 pm IST through Video Conferencing/ Other Audio-Visual Means. The details are enclosed in the letter attached.27-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Report for the financial year 2022-23 including the Notice of Thirty-first Annual General Meeting ('31st AGM') of the Company. The 31st AGM of the members of Sun Pharmaceutical Industries Limited will be held on Monday, August 28, 2023 at 3:00 p.m. IST through Video Conferencing/ Other Audio-Visual Means. The Cut-off date for the purpose of determining the Members eligible to vote on the resolutions set out in the Notice of 31st AGM is Monday, August 21, 2023. The Remote e-voting period begins on Thursday, August 24, 2023 at 09:00 a.m. IST and ends on Sunday, August 27, 2023 at 05:00 p.m. IST.27-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation -July 202321-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed the updates w.r.t. one of the investee entities.20-07-2023
Golden Crossovers: Sun Pharma among 6 stocks signalling further bullishness
Golden Cross is an important technical indicator of bullishness. It occurs when the short-term moving average crosses over the major long-term moving average on the upside. These stocks' 50-day simple moving averages (SMA) crossed their 200-day SMAs on July 18.19-07-2023
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sun Pharma to announce first quarter results on August 03, 202317-07-2023